Literature DB >> 3587271

Serotonin uptake in blood platelets of Duchenne muscular dystrophy patients.

R C Arora, R W Kuncl, J Morgan, L Cohen, H Y Meltzer.   

Abstract

Serotonin (5-HT) uptake was studied in the blood platelets of 10 patients with Duchenne-type muscular dystrophy (DMD) and 7 age-matched controls. Vmax (maximum number of uptake sites) of platelet 5-HT uptake in the DMD patients was significantly less than that of the normal controls. There was no difference in the affinity for 5-HT (Km) between the two groups. There was a significant negative correlation between serum creatine kinase activity and Km of 5-HT uptake in blood platelets of these patients. However, no correlation was found between Km or Vmax and ambulatory status of DMD.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3587271     DOI: 10.1002/mus.880100413

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  4 in total

1.  Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Trent A Waugh; Eric Horstick; Junguk Hur; Samuel W Jackson; Ann E Davidson; Xingli Li; James J Dowling
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

2.  Experimental serotonin myopathy as an animal model of muscle degeneration and regeneration in muscular dystrophy.

Authors:  H Narukami; K Yoshioka; J Zhao; T Miike
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

3.  Effect of serotonin modulation on dystrophin-deficient zebrafish.

Authors:  Janelle M Spinazzola; Matthias R Lambert; Devin E Gibbs; James R Conner; Georgia L Krikorian; Prithu Pareek; Carlo Rago; Louis M Kunkel
Journal:  Biol Open       Date:  2020-08-28       Impact factor: 2.422

Review 4.  Caenorhabditis elegans as a Model System for Duchenne Muscular Dystrophy.

Authors:  Rebecca A Ellwood; Mathew Piasecki; Nathaniel J Szewczyk
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 6.208

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.